RIVAROXABAN: AN ORAL DIRECT INHIBITOR OF FACTOR X-A. Int. Res. J. Pharm. 2024;2(8):1-5. Accessed May 26, 2026. https://irjponline.org/index.php/irjp/article/view/1833